Clinical Trial Update: Guilingji Capsule for Mild-to-moderate Cognitive Impairment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Guilingji Capsule in mild-to-moderate cognitive impairment (cognitive dysfunction).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Dysfunction
• Cognitive Impairment

Drugs mentioned

• Guilingji Capsule

Snippet

Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences | Conditions: Cognitive Dysfunction | Phase 2 | Status: UNKNOWN